| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 125.10B | 124.77B | 122.56B | 134.06B | 116.75B | 101.17B |
| Gross Profit | 15.30B | 14.62B | 13.50B | 14.01B | 12.97B | 10.49B |
| EBITDA | 14.05B | 14.45B | 12.32B | 14.37B | 11.19B | 9.57B |
| Net Income | 6.12B | 6.04B | 4.63B | 6.16B | 5.60B | 4.64B |
Balance Sheet | ||||||
| Total Assets | 170.14B | 165.41B | 160.32B | 137.16B | 129.89B | 125.53B |
| Cash, Cash Equivalents and Short-Term Investments | 24.73B | 27.03B | 21.99B | 19.81B | 14.57B | 13.35B |
| Total Debt | 36.18B | 37.95B | 42.27B | 28.43B | 30.32B | 32.88B |
| Total Liabilities | 68.89B | 69.83B | 71.11B | 57.42B | 57.10B | 58.54B |
| Stockholders Equity | 96.76B | 91.19B | 85.52B | 76.61B | 70.21B | 64.69B |
Cash Flow | ||||||
| Free Cash Flow | 6.51B | 11.42B | -10.73B | 8.07B | 4.68B | 5.28B |
| Operating Cash Flow | 11.22B | 15.14B | 7.28B | 11.60B | 7.26B | 8.62B |
| Investing Cash Flow | -4.70B | -3.11B | -18.04B | -2.96B | -2.52B | -3.48B |
| Financing Cash Flow | -6.19B | -7.43B | 12.20B | -3.26B | -3.59B | -3.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥14.05B | 8.60 | ― | 3.04% | 4.45% | 29.58% | |
78 Outperform | ¥132.16B | 11.68 | ― | 2.12% | 3.09% | 8.50% | |
75 Outperform | ¥18.32B | 6.27 | ― | 2.46% | 7.13% | 16.09% | |
73 Outperform | ¥80.39B | 6.51 | ― | 3.48% | 4.17% | 24.54% | |
73 Outperform | ¥14.77B | 7.26 | ― | 3.85% | 4.96% | 38.47% | |
68 Neutral | ¥76.28B | 9.20 | ― | 3.63% | 2.67% | 18.02% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |